Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, HJ | - |
dc.contributor.author | Kim, HJ | - |
dc.contributor.author | Kwak, JH | - |
dc.contributor.author | Chun, HO | - |
dc.contributor.author | Kim, JH | - |
dc.contributor.author | Park, H | - |
dc.contributor.author | Kim, DH | - |
dc.contributor.author | Lee, YS | - |
dc.date.accessioned | 2024-01-21T10:05:50Z | - |
dc.date.available | 2024-01-21T10:05:50Z | - |
dc.date.created | 2021-09-01 | - |
dc.date.issued | 2002-09 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/139214 | - |
dc.description.abstract | During the search for naturally occurring cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) inhibitors, it was found that the extracts from Sophora flavescens exhibit potent inhibitory activity against cGMP PDE5 prepared from rat diaphragm. Therefore, the inhibitory activities of five flavonoids, kushenol H (1), kushenol K (2), kurarinol (3), sophoflavescenol (4) and kuraridine (5), isolated from S. flavescens were measured against cGMP PDE5 to identify potent cGMP PDE5 inhibitory constituents. Among tested compounds, sophoflavescenol (4), a C-8 prenylated flavonol, showed the most potent inhibitory activity (IC50 = 0.013 muM) against cGMP PDE5 with 31.5- and 196.2-fold selectivity over PDE3 and PDE4, respectively. Kinetic analysis revealed that sophoflavescenol was a mixed inhibitor of PDE5 with a K-i value of 0.005 muM. (C) 2002 Elsevier Science Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | A prenylated flavonol, sophoflavescenol: A potent and selective inhibitor of cGMP phosphodiesterase 5 | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/S0960-894X(02)00401-8 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.12, no.17, pp.2313 - 2316 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 12 | - |
dc.citation.number | 17 | - |
dc.citation.startPage | 2313 | - |
dc.citation.endPage | 2316 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000177603200012 | - |
dc.identifier.scopusid | 2-s2.0-1842842609 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | SILDENAFIL | - |
dc.subject.keywordPlus | RELAXATION | - |
dc.subject.keywordAuthor | sophoflavescenol | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.